Latest Share Based Payments News

Page 1 of 9
Catapult Sports Ltd (ASX:CAT) delivered a 20.8% revenue increase to US$140.7 million in FY26, driven by strong SaaS growth and strategic acquisitions, while management EBITDA surged 67%. Despite this, the company reported a net loss of US$24 million, impacted by non-cash expenses and acquisition costs.
Sophie Babbage
Sophie Babbage
20 May 2026
Titan Minerals boosts its Dynasty Gold Project resource to 3.9 million ounces of gold and 26.1 million ounces of silver, driven by extensive drilling at Cerro Verde and discovery of porphyry mineralisation at Kaliman. A major 30,000m drilling campaign is planned for 2026 alongside advancing feasibility studies.
Maxwell Dee
Maxwell Dee
30 Apr 2026
Neuren Pharmaceuticals reported a solid A$30.4 million net profit in 2025, powered by a 15% rise in DAYBUE® royalties. The company is progressing its NNZ-2591 Phase 3 trial for Phelan-McDermid syndrome and has initiated a share buy-back amid perceived undervaluation.
Ada Torres
Ada Torres
24 Apr 2026
Merino & Co. Limited reported a 60.5% drop in revenue and a 28.2% increase in net loss for the half-year ending December 2025, reflecting a strategic investment phase aimed at future growth. The company is expanding production capacity and building inventory ahead of wholesale expansion, signaling a pivot towards revenue acceleration.
Victor Sage
Victor Sage
27 Feb 2026
Yojee Limited reported a 9% revenue increase driven by software activities, while net losses widened due to accelerated investment in its MOSAIC platform and joint venture costs. The company maintains a robust cash balance and has strengthened its leadership ahead of a mid-2026 commercial launch.
Sophie Babbage
Sophie Babbage
27 Feb 2026
Recce Pharmaceuticals reported a doubling of its net loss for the half-year ended December 2025 amid significant progress in its anti-infective drug development and a substantial funding boost. The company is advancing Phase 3 trials and expanding its patent portfolio while managing financial pressures.
Ada Torres
Ada Torres
27 Feb 2026
Provaris Energy reported a 59% increase in its half-year loss to $2.09 million, driven by higher project development costs amid progress in hydrogen and carbon capture technologies. The company raised over $3.5 million in capital and is advancing key milestones for its hydrogen shipping and liquid CO2 tank projects.
Maxwell Dee
Maxwell Dee
27 Feb 2026
Codeifai Limited reported a 26% revenue decline to $598,497 for 2025 alongside a sharp increase in net loss to $6.22 million, driven by strategic investments and market challenges. The company’s pivot to self-service SaaS platforms, including a key acquisition post-year-end, signals a transformative but uncertain path forward.
Sophie Babbage
Sophie Babbage
27 Feb 2026
Advanced Energy Minerals reports a sharp revenue increase alongside a substantial net loss for 2025, completing a major plant expansion and raising $44.8 million in its IPO.
Maxwell Dee
Maxwell Dee
27 Feb 2026
Racura Oncology reported a $4.1 million loss for H1 FY26, reflecting heavy investment in clinical trials and intellectual property. The company also boosted cash reserves through capital raises and rebranded from Race Oncology.
Ada Torres
Ada Torres
27 Feb 2026
De.mem Limited reported a 20% increase in revenue to $29.9 million for FY2025, alongside a reduced net loss and its first full-year positive adjusted EBITDA. The company also completed the acquisition of Core Chemicals, expanding its specialty chemicals footprint in the gold mining sector.
Victor Sage
Victor Sage
27 Feb 2026
Sparc Technologies Limited reported a significant net loss of $1.86 million for the half-year ended December 2025, highlighting ongoing financial pressures despite continued R&D efforts. The company flagged material uncertainty over its ability to continue as a going concern.
Sophie Babbage
Sophie Babbage
27 Feb 2026